JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Metallus
MTUS
$904M
| $3.12M | ﹤0.01% |
170,081
+9,148
| +6% | +$171K |
|
3052
Harmony Gold Mining
HMY
$12.1B
| $3.11M | ﹤0.01% |
758,460
+119,282
| +19% | +$425K |
|
3053
BioNTech
BNTX
$23.4B
| $3.11M | ﹤0.01% |
24,955
-2,029
| -8% | -$279K |
|
3054
PUT
iRhythm Holdings
IRTC
$4.17B
| $3.1M | ﹤0.01% |
+25,000
| New | +$2.71M |
|
|
GDEN
3055
DELISTED
Golden Entertainment
GDEN
| $3.1M | ﹤0.01% |
71,242
+32,667
| +85% | +$1.32M |
|
|
XRN
3056
Chiron Real Estate Inc
XRN
$491M
| $3.1M | ﹤0.01% |
68,066
-2,742
| -4% | -$138K |
|
3057
PUT
Packaging Corp of America
PKG
$22.8B
| $3.1M | ﹤0.01% |
+22,300
| New | +$3.03M |
|
3058
Tyra Biosciences
TYRA
$1.51B
| $3.09M | ﹤0.01% |
192,509
-6,698
| -3% | -$79.7K |
|
3059
CALL
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
| $3.09M | ﹤0.01% |
76,500
-157,600
| -67% | -$6.66M |
|
3060
ZipRecruiter
ZIP
$386M
| $3.09M | ﹤0.01% |
193,960
+22,220
| +13% | +$401K |
|
3061
CALL
CVS Health
CVS
$124B
| $3.08M | ﹤0.01% |
41,500
-97,500
| -70% | -$8.18M |
|
3062
Frontdoor
FTDR
$5.96B
| $3.08M | ﹤0.01% |
110,636
+22,015
| +25% | +$582K |
|
3063
CALL
Axalta
AXTA
$7.99B
| $3.08M | ﹤0.01% |
+101,700
| New | +$2.92M |
|
3064
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $3.08M | ﹤0.01% |
40,110
-47,486
| -54% | -$3.6M |
|
3065
CALL
Illumina
ILMN
$28.8B
| $3.07M | ﹤0.01% |
13,570
-3,392
| -20% | -$694K |
|
|
VSTO
3066
DELISTED
Vista Outdoor Inc.
VSTO
| $3.07M | ﹤0.01% |
110,736
+21,344
| +24% | +$584K |
|
|
APMI
3067
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
| $3.07M | ﹤0.01% |
295,000
| – | – |
|
3068
IDT Corp
IDT
$1.66B
| $3.06M | ﹤0.01% |
89,765
-13,250
| -13% | -$408K |
|
|
AVNS
3069
DELISTED
Avanos Medical
AVNS
| $3.06M | ﹤0.01% |
102,820
+9,481
| +10% | +$275K |
|
3070
Ameresco
AMRC
$1.48B
| $3.06M | ﹤0.01% |
62,062
+4,394
| +8% | +$233K |
|
3071
Green Dot
GDOT
$771M
| $3.05M | ﹤0.01% |
177,775
-109,859
| -38% | -$1.92M |
|
3072
Collegium Pharmaceutical
COLL
$875M
| $3.05M | ﹤0.01% |
127,235
+4,061
| +3% | +$108K |
|
|
TEN
3073
Tsakos Energy Navigation Ltd
TEN
$1.25B
| $3.05M | ﹤0.01% |
157,090
+87,175
| +125% | +$1.7M |
|
3074
AtriCure
ATRC
$2.25B
| $3.05M | ﹤0.01% |
73,533
+12,652
| +21% | +$525K |
|
3075
Coastal Financial
CCB
$802M
| $3.05M | ﹤0.01% |
84,607
-5,060
| -6% | -$218K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.